For example, XAV939 and ICG‐001, two Wnt/β-catenin inhibitors with different modes of action, reduced ovarian cancer cell proliferation by suppressing the expression of cyclin D1 and c-myc (30). The gene discussed is CCND1; the disease is ovarian carcinoma.